In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.
about
Aspergillus infections in transplant recipients.Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.New methods to assess susceptibilities of Aspergillus isolates to caspofungin.Coding tandem repeats generate diversity in Aspergillus fumigatus genes.Effect of caspofungin on metabolite profiles of Aspergillus species determined by nuclear magnetic resonance spectroscopyEmerging echinocandins for treatment of invasive fungal infections.In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreusIn vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.Combination antifungal therapy: the new frontier.A comparative evaluation of properties and clinical efficacy of the echinocandins.Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactionsCombinatorial strategies for combating invasive fungal infections.Echinocandins in antifungal pharmacotherapy.In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization.In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae.Clinical efficacy and tolerability of caspofungin in a renal transplant patient with Aspergillus flavus lung infection: case report.In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans.Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.In vitro evaluation of antifungal drug combinations against Sarocladium (Acremonium) kiliense, an opportunistic emergent fungus resistant to antifungal therapies.Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus.Comparison Between Etest and Broth Microdilution Methods for Testing Itraconazole-Resistant Aspergillus fumigatus Susceptibility to Antifungal Combinations.
P2860
Q33719294-AD9E77AB-FA74-42EB-A3FE-68B50B1E2A9AQ33857685-5EA688BB-954E-4CC5-B323-676B4FB117EDQ34956645-276DB05D-AFC3-45A4-8F85-BFD249603A4BQ35947161-5AB03850-4030-428D-AE83-6E683A7BCF71Q36295480-72DF4BC6-FB82-4890-8DE1-8B2CCFFCC74FQ36458402-9E02F836-100E-4728-A868-54059683B9F2Q36492208-01CE0DEC-545D-4600-A33B-769B91158EAAQ36558484-93E1AC2A-CCAF-4C33-977F-2D4E7ED2DF0DQ36895652-0D3C7FCB-CF05-4C7B-A0F0-4C115D177D5DQ36895839-7CD549BC-D2DC-48FF-B9CE-559A333B04CAQ37263780-99426711-1BDD-4240-B04C-32E69A712AD3Q37705303-3E3E30B0-2FC6-418B-ABD7-FB6D0CA551E2Q39458862-44026A9E-F565-45FE-8A4F-FF016AE9E73AQ39913400-D3078FE3-4C04-485F-8B57-D2D86E595BFDQ39954754-51CD7B7C-1E52-465D-8932-F014C028DD7DQ40164956-DB05305C-4E93-40D2-94CE-FD6C519B71FDQ40463769-AE6202B0-414D-4948-BF3A-A647EAA45FC2Q41815954-A85A5A3E-678B-4A38-9B1E-5A1CC212F5BCQ41835779-35436516-0440-44F1-966D-8CCA2AB1EE15Q41973262-90DA6BAC-C133-4793-9607-BDDD0F8E1095Q42689671-E6D32B17-AA8C-4BA4-BBC6-9333419C33F4Q44619968-CDE1771A-6D9B-443B-B25C-1E1555DE28CBQ46290055-C8466450-4F61-4989-A4AF-4A2B60329341
P2860
In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
In vitro synergy of caspofungi ...... tive concentration end points.
@en
In vitro synergy of caspofungi ...... tive concentration end points.
@nl
type
label
In vitro synergy of caspofungi ...... tive concentration end points.
@en
In vitro synergy of caspofungi ...... tive concentration end points.
@nl
prefLabel
In vitro synergy of caspofungi ...... tive concentration end points.
@en
In vitro synergy of caspofungi ...... tive concentration end points.
@nl
P2093
P2860
P1476
In vitro synergy of caspofungi ...... tive concentration end points.
@en
P2093
Itamar Shalit
Nir Osherov
Yona Shadkchan
Zmira Samra
P2860
P304
P356
10.1128/AAC.47.4.1416-1418.2003
P407
P577
2003-04-01T00:00:00Z